<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02425982</url>
  </required_header>
  <id_info>
    <org_study_id>65/13/03/02/2014</org_study_id>
    <nct_id>NCT02425982</nct_id>
  </id_info>
  <brief_title>Finnish Tennis Elbow Trial Pilot Study</brief_title>
  <acronym>FINITE</acronym>
  <official_title>Finnish Tennis Elbow Trial Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the natural course and the results of operative treatment of
      chronic tennis elbow (TE). Chronic is defined as symptoms having lasted for more than a year.
      The investigators will also study the effect of pain catastrophising on the subjective
      outcome, the patient acceptable symptomatic state and the response shift phenomenon in TE.
      The study will also ascertain the feasibility of a multi-center randomised, controlled trial
      (RCT), and test and refine the co-operation and interaction of the planned RCT centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

        1. To study the natural course of tennis elbow/spontaneous recovery of chronic (lasting for
           over 12 months) tennis elbow and the results of surgery in a pragmatic setting.

        2. To investigate the patients' expectations of the treatment, and define the patient
           acceptable symptomatic state, or PASS, in tennis elbow.

        3. To investigate the effect of pain behaviour on treatment results and PASS.

        4. To delineate the existence of a potential &quot;response shift&quot; -phenomenon in patients with
           a tennis elbow.

        5. To determine the feasibility of a prospective, placebo-controlled, randomised trial by
           finding out the actual number of patients in each center and those that may be suitable
           for the FINITE-RCT. The investigators will also test the functioning and response of the
           planned outcome measures in this environment and for this purpose.

      Study setting The study is carried out as a prospective open-label multi-center cohort study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Global improvement</measure>
    <time_frame>6 months</time_frame>
    <description>A six-point Likert scale (much worse - worse - no change - better - much better - complete recovery) will be used and the patient is asked how the elbow symptoms are compared to the situation at the time of the initial visit and inclusion to the study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxford Elbow Score</measure>
    <time_frame>6 months</time_frame>
    <description>Oxford Elbow Score (OES) is a three-dimensional questionnaire consisting of 12 multiple-choice questions answered by the patient. OES has been validated for patients with surgically treated elbow problems. OES is the most robust elbow-specific PROM available currently.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QuickDASH</measure>
    <time_frame>up to 10 years</time_frame>
    <description>QuickDASH is a validated patient reported outcome measure of the function the upper extremities. It consists of 11 questions and 4 work-related questions. An approved Finnish translation has been made earlier. The outcome measure will be assessed as a secondary outcome at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Success is defined at any follow-up time point as patients who report &quot;much better&quot; or &quot;complete recovery&quot; in the second primary outcome question.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapses</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Relapses are calculated from the Likert answers so that if the patient reports &quot;much better&quot; or &quot;completely healed&quot; at time point X and the answer is &quot;better&quot; or any of the poorer alternatives on follow-up point X+1, this is interpreted as a relapse for X+1 point in time. Relapses are calculated for each follow-up point in time and the patients are considered to remain in &quot;relapse&quot; until they report &quot;much better&quot; or &quot;completely healed&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with the treatment process</measure>
    <time_frame>up to 10 years</time_frame>
    <description>this is evaluated with the question &quot;On a scale of 0 to 10, (with 10 on as 'very satisfied' and 0 as 'very dissatisfied'), how satisfied are you with the treatment you have received as a whole?&quot; The outcome measure will be assessed as a secondary outcome at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time off work</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Number of sick leave days due to elbow symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications and adverse effects</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Complications and adverse events related to treatment of the elbow. Predefined complications are: infection, iatrogenic injuries (especially nerve), crps, anaesthetic complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global improvement</measure>
    <time_frame>up to 10 years</time_frame>
    <description>A six-point Likert scale (much worse - worse - no change - better - much better - complete recovery) will be used and the patient is asked how the elbow symptoms are compared to the situation at the time of the initial visit and inclusion to the study. The outcome measure will be assessed at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Elbow Score</measure>
    <time_frame>up to 10 years</time_frame>
    <description>OES will be assessed as a secondary outcome at 6, 12, 26 and 52 weeks and then at 2, 3, 4, 5 and 10 years</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Tennis Elbow</condition>
  <arm_group>
    <arm_group_label>Conservative treatment</arm_group_label>
    <description>Patients who will opt conservative treatment or patients treated conservatively by surgeon decision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative treatment</arm_group_label>
    <description>Patients who opt for surgery when offered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Operative treatment</intervention_name>
    <description>The exact treatment depends on the surgeon, but the majority are anticipated to be elbow arthroscopy followed by either arthroscopic or open extensor carpi radialis brevis release.</description>
    <arm_group_label>Operative treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conservative treatment</intervention_name>
    <description>The treatment consists of physiotherapy, activity modification, pain medication and watchful waiting. Injection therapies will be avoided.</description>
    <arm_group_label>Conservative treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who seek advice or treatment at the outpatient clinics of the centers taking
        part in the study will be assessed for eligibility. Those fulfilling the criteria defined
        below will be asked to participate.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinically diagnosed tennis elbow defined as: Pain on the lateral side of the elbow,
             made worse by pressure applied on the lateral epicondyle of the humerus and during
             resisted extension of the wrist or when making a fist with the elbow joint straight.

          2. Duration of symptoms over 10 months

          3. Age between 35 and 60 years

          4. Ability to fill in Finnish questionnaires

          5. Written informed consent

        Exclusion Criteria:

          1. Earlier fracture or dislocation in the elbow joint area

          2. Earlier surgical treatment of the same elbow joint

          3. Congenital deformity in the elbow

          4. Systemic muscle, tendon, nerve or joint disease

          5. Other problems causing pain the elbow joint:

               1. Pain in the medial epicondyle of the elbow

               2. Pain in the biceps muscle tendon

               3. Painful snapping or crepitus of elbow joint

               4. Instability of elbow joint (table top, posterolateral drawer test)

          6. A passive movement limitation of more than 10 degrees in the elbow joint

          7. Abnormal finding in an elbow joint X-ray. An elbow joint X-ray is a routine
             examination of elbow symptoms.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teppo LN Järvinen, MD, professor</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tuomas Lähdeoja, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mikko Salmela, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teemu Karjalainen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Finland Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pirjo Toivonen, coordinator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University, Hatanpää Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tuomas Lähdeoja, MD</last_name>
    <phone>+358504272408</phone>
    <email>tuomas.lahdeoja@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Teppo LN Järvinen, MD, professor</last_name>
    <phone>+3854711</phone>
    <email>teppo.jarvinen@helsinki.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Töölö Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00240</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tuomas Lähdeoja, MD</last_name>
      <phone>+358504272408</phone>
      <email>tuomas.lahdeoja@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Mikko Salmela, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tuomas Lähdeoja, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teppo Järvinen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Karelia Central Hospital</name>
      <address>
        <city>Joensuu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lauri Lindroos, MD</last_name>
    </contact>
    <investigator>
      <last_name>Lauri Lindroos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tarja Soininvaara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Finland Central Hospital</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teemu Karjalainen, MD, PhD</last_name>
      <email>teemu.karjalainen@ksshp.fi</email>
    </contact>
    <investigator>
      <last_name>Teemu Karjalainen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Toni Luokkala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kymenlaakso Central Hospital</name>
      <address>
        <city>Kotka</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arto Toivanen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Arto Toivanen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Imke Höfling, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kuopio Unversity Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Juntunen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Matti Juntunen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jari Halonen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Päijät-Häme Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juuso Tamminen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Juuso Tamminen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marko Sunnari, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marko Sunnari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janne Soikkeli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Satakunta Central Hospital</name>
      <address>
        <city>Pori</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorma Panula, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jorma Panula, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pekka Petäjä, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pekka Petäjä, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antti Miettinen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hatanpää Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kari Kanto, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kari Kanto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampere Unversity Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jouni Havulinna, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jouni Havulinna, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olli Leppänen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Vastamäki, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Markus Pääkkönen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tero Kotkansalo, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2015</study_first_posted>
  <last_update_submitted>January 3, 2017</last_update_submitted>
  <last_update_submitted_qc>January 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University</investigator_affiliation>
    <investigator_full_name>Tuomas Lahdeoja</investigator_full_name>
    <investigator_title>MD, specialist in orthopaedics and traumatology</investigator_title>
  </responsible_party>
  <keyword>Tennis Elbow</keyword>
  <keyword>Lateral elbow pain</keyword>
  <keyword>Latera epicondylitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

